Apoptosis inducer 61
Apoptosis inducer 61 (Compound 4E) is an Apoptosis inducer. Apoptosis inducer 61 significantly downregulates the expression of BIRC3 and activates Apoptosis. Anticancer agent 313 exhibits anticancer activity against ER+ breast cancer cells, triple-negative breast cancer cells, and gastric cancer cells.
For research use only. We do not sell to patients.
- Formula: C16H12FN7
- Molecular Weight:321.31
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
BIRC3 |
Apoptosis inducer 61 (1.56-200 μM; 48 h) potently inhibits the viability of MCF-7, MDA-MB-231 and HGC-27 cancer cells, with IC50 values of 5.61 μM, 8.18 μM and 5.68 μM, respectively; this compound exhibits selective toxicity toward cancer cells compared to non-malignant CCD-1072Sk cells[1].
Apoptosis inducer 61 (5.61 μM (MCF-7), 8.18 μM (MDA-MB-231); 48 h) induces apoptosis in MCF-7 and MDA-MB-231 breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 breast cancer cells, MDA-MB-231 breast cancer cells
-
Concentration:5.61 μM (MCF-7); 8.18 μM (MDA-MB-231)
-
Incubation Time:48 h
-
Result:Showed 12.35% apoptotic cells (8.73% early, 3.62% late) and 1.71% necrotic cells in MCF-7 cells.
Showed 9.78% apoptotic cells (5.54% early, 4.24% late) and 0.38% necrotic cells in MDA-MB-231 cells.
Chemical Information
-
Molecular Weight 321.31
-
Formula C16H12FN7
-
SMILES
FC1=CC=C(C=C1)C2=CN(N=N2)CC3=NN(C=C3)C4=NC=NC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)